State of Wyoming - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
State of Wyoming ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$15,000
-57.1%
12,984
-33.2%
0.01%
-68.2%
Q2 2022$35,000
-48.5%
19,436
-42.0%
0.02%
-35.3%
Q1 2022$68,000
-1.4%
33,498
+31.8%
0.03%
+6.2%
Q4 2021$69,000
+30.2%
25,419
+115.3%
0.03%
-5.9%
Q3 2021$53,000
-24.3%
11,805
-2.0%
0.03%
-22.7%
Q2 2021$70,00012,0420.04%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders